Elsevier

Cytokine

Volume 20, Issue 4, November 2002, Pages 184-190
Cytokine

Regular Articles
PROGNOSTIC ROLE OF SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR, BASIC FIBROBLAST GROWTH FACTOR AND NITRIC OXIDE IN PATIENTS WITH COLORECTAL CARCINOMA

https://doi.org/10.1006/cyto.2002.1993Get rights and content

Abstract

Recently, angiogenesis has gained an increasing interest as a prognostic factor in a variety of solid tumours. In this study we aimed to assess the prognostic role of serum vascular endothelial growth factor (VEGF), basic fibroblast growth factor (b-FGF) and nitric oxide (NO) levels in patients with colorectal carcinoma (CRC).

A total of 52 consecutive colorectal cancer patients with stage I to IV disease was included. In addition to routine laboratory and staging procedures, serum VEGF, b-FGF levels, and nitrate levels as a surrogate marker for in-vivo NO production were assayed.

Serum VEGF concentrations, adjusted to the platelet count were found to be a significant factor for overall survival in univariate analysis (P=0.033). A new angiogenic index (AI), derived from serum VEGF and nitrate concentrations, was established. AI is the only independent prognostic factor of survival in all patients (P=0.008, Cox regression analysis). Likewise, AI is also significant prognostic factor for disease-free survival (DFS) in patients with operable CRC (P=0.032, Cox regression analysis).

In conclusion, serum VEGF and NO levels have prognostic role in patients with CRC and the new angiogenesis index using the serum levels of the factors seem to be useful.

References (36)

  • RTP Poon et al.

    Clinical implications of circulating angiogenic factors in cancer patients

    J Clin Oncol

    (2001)
  • A Eroglu et al.

    Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer

    Br J Cancer

    (1999)
  • E Pipili-Synetos et al.

    Nitric oxide is involved in the regulation of angiogenesis

    Br J Pharmacol

    (1993)
  • A Papapetropolos et al.

    Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

    J Clin Invest

    (1997)
  • M Ziche et al.

    Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

    J Clin Invest

    (1997)
  • D Fukumura et al.

    Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

    Proc Natl Acad Sci USA

    (2001)
  • JA Powell et al.

    Anti-angiogenesis efficacy of nitric oxide donors

    J Cellular Biochem

    (2000)
  • A RayChaudhury et al.

    Inhibition of endothelial cell proliferation and bFGF-induced phenotypic modulation by nitric oxide

    J Cell Biochem

    (1996)
  • Cited by (49)

    • Colorectal Cancer

      2019, Abeloff’s Clinical Oncology
    • Colorectal Cancer

      2014, Abeloff's Clinical Oncology: Fifth Edition
    • Impact of portal branch ligation on tissue regeneration, microcirculatory response and microarchitecture in portal blood-deprived and undeprived liver tissue

      2011, Microvascular Research
      Citation Excerpt :

      However, the authors concluded that the induction of these intracellular stress response proteins and immediate-early genes in the atrophying liver tissue may have a cytoprotective function and a role in regulating tissue repair under un-physiological hypoxic conditions (Mueller et al., 2005). VEGF has been shown to be a key player in tumor angiogenesis resulting in growth of tumor and metastases (Akbulut et al., 2002; Ferrara et al., 2003; Folkman, 1995; Takahashi et al., 1995; Warren et al., 1995). The present analysis of VEGF immunohistochemistry showed strongly VEGF expressing hepatocytes in the ligated lobes at day 1 after PBL.

    View all citing articles on Scopus
    f1

    Correspondence to: Dr Hakan Akbulut, Department of Medical Oncology, Ibni Sina Hospital, Ankara University Faculty of Medicine, Sihhiye, Ankara 06100, Turkey. Tel: +90 312 3103333; Fax: +90 312 3121650; E-mail:[email protected]

    View full text